Fabian Kausche Board of Director Membership

Home

Insights

Fabian Kausche Board Membership

Last Updated on: Nov 23, 2024

About Fabian Kausche

Dr. Fabian Kausche is a distinguished professional with extensive experience in finance and governance.
He is a Chartered Accountant, Cost Accountant, and Company Secretary, and has been recognized with multiple accolades, including the ICAI CFO Award and the CNBC TV-18 CFO Award.
Additionally, he is a CII-Fulbright Fellow from Carnegie Mellon University, USA. Beyond his role at Sequent Scientific Ltd, he serves as the Chairman of the Board for PetMedix in Cambridge and is actively involved in philanthropic efforts through his leadership of the Increate Foundation and his advisory position at Educo, a school support NGO. His diverse expertise contributes significantly to the strategic direction and governance of Sequent Scientific Ltd, a leading integrated pharmaceutical company specializing in animal health and actively engaged in global operations.

List of Companies Associated with Fabian Kausche

Company Name	Position Held	Market Cap	Sector	Date Of Appointment

Sequent Scientific Ltd

Non-Exec & Non-Independent Dir

5611.85

Pharmaceuticals

Mar, 2023

Company Name	Position Held
Sequent Scientific Ltd	Non-Exec & Non-Independent Dir

PRICE

<p>The current market price or CMP refers to the price of those companies associated with Fabian Kausche at which the securities are trading in the share market.</p> <br> <h2>Current price in Over-the-counter costs:</h2> <p>The following current price of those companies associated with Fabian Kausche depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC).</p> <br> <h2>Current Price in Bond Market: </h2> <p>The current price of a bond of those companies associated with Fabian Kausche is determined by measuring the actual interest rate against the bid-related interest rate.</p> <br> <p>The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.</p>

Historical Share prices

* All values are in Rupees

Fabian Kausche Sector Specific Experience

About Fabian Kausche's work experience

Fabian Kausche is currently a Non-Exec & Non-Independent Dir in Sequent Scientific Ltd (as of Mar 2024).
Fabian Kausche is serving the company - Sequent Scientific Ltd at this position since 2023 for the last 2+ years.
Prior to becoming Non-Exec & Non-Independent Dir, Fabian Kausche was Additional Director of Sequent Scientific Ltd for 1 year in 2020.

FAQ's related Fabian Kausche

Who is Fabian Kausche

Dr. Fabian Kausche is a distinguished professional with extensive experience in finance and governance. He is a Chartered Accountant, Cost Accountant, and Company Secretary, and has been recognized with multiple accolades, including the ICAI CFO Award and the CNBC TV-18 CFO Award. Additionally, he is a CII-Fulbright Fellow from Carnegie Mellon University, USA. Beyond his role at Sequent Scientific Ltd, he serves as the Chairman of the Board for PetMedix in Cambridge and is actively involved in philanthropic efforts through his leadership of the Increate Foundation and his advisory position at Educo, a school support NGO. His diverse expertise contributes significantly to the strategic direction and governance of Sequent Scientific Ltd, a leading integrated pharmaceutical company specializing in animal health and actively engaged in global operations.

Which companies does Fabian Kausche serve as a board member for?

Fabian Kausche serves as a board member for: Sequent Scientific Ltd

What positions has Fabian Kausche held in his/her career?

Throughout their career, Fabian Kausche has held key positions such as Non-Exec & Non-Independent Dir,Additional Director, contributing to the growth and success of each company.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*